The Link Between Gum Disease and Dementia
Periodontitis is a chronic inflammatory disease that destroys the gums, bone, and tissues supporting the teeth. It affects roughly 47% of adults over age 30 in the United States, according to data from the Centers for Disease Control and Prevention. Alzheimer's disease is the most common form of dementia, affecting an estimated 6.7 million Americans over age 65.
Over the past two decades, epidemiological studies have consistently found that people with chronic gum disease have a higher risk of developing Alzheimer's disease and other forms of dementia compared to people with healthy gums. A 2020 meta-analysis examining multiple large-scale studies found that periodontitis was associated with a significantly increased risk of cognitive impairment and dementia.
These population-level studies cannot tell us whether gum disease contributes to Alzheimer's or whether the two conditions simply share common risk factors such as aging, smoking, diabetes, and chronic inflammation. That is why laboratory and clinical research has focused on identifying specific biological pathways that could explain a causal connection.
P. gingivalis: The Bacteria at the Center of the Research
Porphyromonas gingivalis (P. gingivalis) is the keystone pathogen in chronic periodontitis. This bacterium does not just damage gum tissue locally. It can enter the bloodstream through inflamed, bleeding gums, a process called bacteremia, and travel to other parts of the body.
What makes P. gingivalis particularly significant in Alzheimer's research is the discovery of this bacterium and its toxic enzymes in Alzheimer's-affected brain tissue. P. gingivalis produces proteases called gingipains, which can destroy proteins and damage neurons. In laboratory studies, gingipains have been shown to break down tau proteins, which are associated with the tangles found in Alzheimer's-affected brains.
How Oral Bacteria May Reach the Brain
There are several proposed routes by which P. gingivalis could travel from the mouth to the brain. The most studied pathway involves the bloodstream. When gum tissue is chronically inflamed and bleeds easily, bacteria enter the blood during everyday activities like chewing and brushing. From the bloodstream, bacteria may cross the blood-brain barrier, which becomes more permeable with age and inflammation.
Another proposed route is direct invasion through the trigeminal nerve, which connects the jaw region to the brainstem. Animal studies have shown that P. gingivalis can travel along nerve fibers. A third mechanism involves the chronic inflammatory response: persistent gum infection triggers systemic inflammation, which in turn may promote neuroinflammation and accelerate neurodegenerative processes already underway.
Key Studies on Gum Disease and Alzheimer's
Several studies have shaped the current understanding of this topic. They range from laboratory work to large population studies.
The 2019 Science Advances Study
The most widely cited study in this field was published in January 2019 in the journal Science Advances by Dominy et al. The research team analyzed brain tissue from deceased Alzheimer's patients and found P. gingivalis DNA in over 90% of the samples examined. They also detected gingipains, the toxic enzymes produced by P. gingivalis, in the brain tissue. Higher levels of gingipains correlated with higher levels of tau and ubiquitin, two proteins associated with Alzheimer's pathology.[1]
The same study tested the effect of P. gingivalis infection in mice. Oral infection with the bacterium led to brain colonization, increased production of amyloid beta (a hallmark of Alzheimer's), and neurodegeneration. When the researchers administered a gingipain inhibitor (a drug that blocks the bacterial enzymes), it reduced the bacterial brain load and decreased neuroinflammation in the mice.
Population and Longitudinal Studies
Several large-scale studies have examined the gum disease and dementia connection at the population level. A 2020 study published in the Journal of Alzheimer's Disease followed over 8,000 adults for up to 18 years and found that those with chronic periodontitis had a significantly higher incidence of Alzheimer's disease, even after adjusting for age, sex, smoking, diabetes, and cardiovascular disease.[2]
A 2021 systematic review and meta-analysis in the Journal of Clinical Periodontology pooled data from multiple studies and confirmed that periodontitis is associated with a higher risk of cognitive decline and dementia. The authors noted that while the association is consistent across studies, the strength of the evidence is moderate, and more controlled clinical trials are needed.[3]
Correlation vs. Causation: What We Know and Do Not Know
The distinction between correlation and causation is critical when interpreting this research. The current evidence clearly shows that gum disease and Alzheimer's disease frequently co-occur and that people with gum disease have a higher statistical risk of developing dementia. What has not been definitively proven is that gum disease causes Alzheimer's.
There are several reasons to be cautious. Both conditions share common risk factors, including older age, smoking, diabetes, cardiovascular disease, and socioeconomic factors that affect healthcare access. People in the early stages of cognitive decline may also neglect oral hygiene, developing gum disease as a consequence of dementia rather than a cause of it. This reverse causation is difficult to rule out even in long-term studies.
The animal studies and the presence of P. gingivalis in brain tissue provide a plausible biological mechanism, which strengthens the case for a potential causal link. However, results from animal models do not always translate directly to humans. Clinical trials testing whether treating gum disease can slow cognitive decline are underway but have not yet produced definitive results.
What This Means for Patients
While the research continues to develop, the practical takeaway is straightforward. Treating and preventing gum disease is beneficial for your overall health, regardless of its relationship to Alzheimer's. Gum disease is already linked to heart disease, diabetes complications, and adverse pregnancy outcomes. If the Alzheimer's connection is confirmed, maintaining periodontal health may add another layer of long-term benefit.
For patients who already have gum disease, getting treatment from a periodontist reduces the bacterial load and chronic inflammation that are at the center of the proposed Alzheimer's connection. Scaling and root planing (deep cleaning), ongoing periodontal maintenance, and in some cases surgical treatment can manage periodontitis and restore gum health.
Oral Hygiene as a Potential Protective Factor
The basic practices of oral hygiene, including brushing twice daily, flossing, and keeping regular dental appointments, reduce the bacteria that cause gum disease. For people concerned about cognitive health, these habits represent a low-risk, low-cost action with potential benefit. Oral hygiene does not replace established Alzheimer's prevention strategies such as physical exercise, cognitive stimulation, cardiovascular health management, and medical care. It may, however, complement them.
For Older Adults and Caregivers
Gum disease becomes more prevalent with age, and people with cognitive decline often have difficulty maintaining oral hygiene. Caregivers of individuals with dementia should be aware that oral health may deteriorate as cognitive function declines. Regular dental checkups and assistance with daily brushing and flossing are important. If gum disease is present, a periodontist can provide a treatment plan appropriate for the patient's overall health and cognitive status.
Current State of the Evidence
Research into the gum disease and Alzheimer's connection is active and evolving. The pharmaceutical company Cortexyme (now Quoram Biosciences) developed a gingipain inhibitor drug called atuzaginstat (COR388) and advanced it to Phase 2/3 clinical trials in Alzheimer's patients. Early results showed that the drug could reduce P. gingivalis levels in cerebrospinal fluid, though the trials encountered setbacks related to side effects.
Multiple research groups around the world are studying the oral-brain connection from different angles: the immune response to oral bacteria, the effect of periodontal treatment on cognitive outcomes, and the role of other oral pathogens beyond P. gingivalis. The next several years of research should provide clearer answers about whether the association is truly causal and whether periodontal treatment can influence Alzheimer's risk or progression.
Find a Periodontist Near You
Every periodontist on My Specialty Dentist has verified specialty credentials. If you have symptoms of gum disease, such as bleeding gums, persistent bad breath, or loose teeth, search by location to find a periodontist in your area for evaluation and treatment.
Search Periodontists in Your Area